Pomelo now covers nearly 7% of U.S. births and is expanding to deliver evidence-based care for women and children across every stage of life. The company's care model combines virtual, round-the-clock clinical care with in-person doula care; this combination of national scale and community support is proven to address key medical, behavioral, and social factors to improve maternal and infant health, with data science and machine learning identifying and managing risks to improve health outcomes and reduce costs.
Cyborg Score Rationale
Pomelo demonstrates strong clinical validation, substantial capital backing (Series C funding), market reach covering 7% of U.S. births, and proven outcomes reducing NICU stays. However, as a private company in a regulated healthcare space with execution dependencies on payer partnerships, full market realization remains conditional.
Top Insights
Secured $92 million in Series C funding with investors including Stripes Group, Andreessen Horowitz, PLUS Capital, Atomico, and Box Group
Demonstrated ability to reduce NICU length of stay by 31%
Offers integrated care across fertility, maternity, pediatric, and midlife health, with access to midwives, primary care physicians, and specialists from preconception to menopause
Acquired The Doula Network to add wrap-around doula services to its virtual and now in-person maternity care offerings
Named Competitors
Maven Clinic — Digital women's and family health across fertility, maternity, pediatrics, and menopause
Wildflower Health — Virtual maternity and women's health platform with integrated care coordination
Delfina — Personalized virtual reproductive health platform
Recent Developments
(January 2026) Expanded mission to cover women and children throughout their lives, moving beyond core maternity care
(December 2024) Named as Highflier among 15 companies in the virtual & hybrid maternity care market
(September 2025) Published data showing virtual care model lowers cost of care, reduces NICU stays, and improves preventive care utilization
(Series C Funding) Secured $92M from top-tier investors including a16z, Stripes, and Atomico to scale expanded care offerings
Open the full interactive Pomelo Care, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.